SVG-103

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameSVG-103
Drug Alias NameSVG-103
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPIK3CA-Related Overgrowth SpectrumNeurodevelopmental DisordersMalformations of Cortical Development +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSoVarGen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSoVarGen Co Ltd
Inactive CompaniesN/A
Active IndicationsPIK3CA-Related Overgrowth SpectrumNeurodevelopmental DisordersMalformations of Cortical Development +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A